FME connects engineering with society and helps Praxa Sense with implementing Afi in clinical practice. Afi will be used for home monitoring of patients with cardiac problems. Read the full Dutch article here: https://www.fme.nl/patienten-met-hartritmestoornis-thuis-slim-gemonitord
The ZorgTech program is a collaboration between Innovation Quarter, MRDH, TNO, Medical Delta and the province of Zuid-Holland which supports innovations. Praxa Sense participates in the ZorgTech program to validate and implement Afi which is a user-friendly health monitor that can be used at home. We are now focused on monitoring and detecting heart rhythm disorders. Within the ZorgTech program, Afi will be tested in clinical practice and medically approved in a clinical research study at Reinier de Graaf Gasthuis. Innovation Quarter visited our office for an interview with Leonard Moonen and the cardiologist Jan Constandse who performs research with Afi. You can read the full Dutch article here: https://www.innovationquarter.nl/item/afi-praxasence/
Praxa Sense received ZonMW subsidy Praxa Sense received €15.000 from ZonMW to transform Afi into a home monitoring device for COVID-19 patients. With this subsidy, Praxa Sense can add oxygen saturation (SpO2) sensors to Afi. Oxygen saturation is a vital parameter that indicates the blood’s oxygen level. Oxygen saturation Praxa Sense develops Afi, a medical multi-sensor system that can detect heart rhythm disorders early by continuous monitoring. Afi monitors heart rate, respiratory rate, ECG and patient activity with an ECG, PPG- and IMU sensor. The PPG-sensor will be adjusted to enable monitoring oxygen saturation as well. Praxa Sense received ZonMW subsidy to complete this project. Within the ZonMW project, the oxygen saturation sensor be developed, validated and manufactured. ZonMW video Leonard Moonen (CEO) and Muriël van Oers (Clinical Research Coordinator), were invited to join a video production of ZonMW. Click here to watch the video. Read more Read more about Afi on our Product page or Contact Us.